ConductScience.org, home

Paper526006

LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.

Flournoy DJ and 1 other. Antimicrob Agents Chemother, 1979. Cited by 25 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas. Papers, record 526006. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526006

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Flournoy DJD J
2Perryman FAF A

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Klebsiella
Microbial Sensitivity Tests
Proteus
Pseudomonas
Serratia
beta-Lactams

Source PubMed

References6

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1109,586Variation in response of Pseudomonas aeruginosa to combinations of gentamicin and carbenicillin.J Okla State Med Assoc1979https://conductscience.org/library/papers/109586PubMed
2464,588Comparison between agar and broth minimum inhibitory concentrations of cefamandole, Cefoxitin, and cefuroxime.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/464588PubMed
3938,021Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/938021PubMed
45,325,707Antibiotic susceptibility testing by a standardized single disk method.Am J Clin Pathol1966https://conductscience.org/library/papers/5325707PubMed
5820,241In vitro evaluation of cefoxitin and cefamandole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/820241PubMed
6727,759Comparative in vitro activity of newer cephalosporins against anaerobic bacteria.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/727759PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
7,103,446Comparison of antimicrobial susceptibility patterns among coagulase-negative staphylococci.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7103446PubMed
7,004,344Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7004344PubMed
6,798,926Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6798926PubMed
6,455,967Pharmacokinetics of moxalactam in subjects with normal and impaired renal function.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6455967PubMed
6,453,555Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6453555PubMed
6,449,905Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6449905PubMed
6,447,671In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.Infection1980https://conductscience.org/library/papers/6447671PubMed
6,214,998Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6214998PubMed
6,214,996Randomized comparative study of moxalactam and cefazolin in the treatment of acute urinary tract infections in adults.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6214996PubMed
3,418,737Profile of patients from a Veterans Administration medical center.J Natl Med Assoc1988https://conductscience.org/library/papers/3418737PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/526006

GET https://conductscience.org/api/papers/v1/526006/authors